These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28717722)

  • 121. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 122. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R; Lawrie TA
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD007102. PubMed ID: 22786502
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Challenge of pediatric oncology in Africa.
    Hadley LG; Rouma BS; Saad-Eldin Y
    Semin Pediatr Surg; 2012 May; 21(2):136-41. PubMed ID: 22475119
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Meeting the challenge of hematologic malignancies in sub-Saharan Africa.
    Gopal S; Wood WA; Lee SJ; Shea TC; Naresh KN; Kazembe PN; Casper C; Hesseling PB; Mitsuyasu RT
    Blood; 2012 May; 119(22):5078-87. PubMed ID: 22461494
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Current management of gestational trophoblastic neoplasia.
    Goldstein DP; Berkowitz RS
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):111-31. PubMed ID: 22244665
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Gestational trophoblastic disease.
    Seckl MJ; Sebire NJ; Berkowitz RS
    Lancet; 2010 Aug; 376(9742):717-29. PubMed ID: 20673583
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Clinical practice. Molar pregnancy.
    Berkowitz RS; Goldstein DP
    N Engl J Med; 2009 Apr; 360(16):1639-45. PubMed ID: 19369669
    [No Abstract]   [Full Text] [Related]  

  • 129. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia.
    FIGO Committee on Gynecologic Oncology
    Int J Gynaecol Obstet; 2009 Apr; 105(1):3-4. PubMed ID: 19322933
    [No Abstract]   [Full Text] [Related]  

  • 130. Surgery and global health: a view from beyond the OR.
    Farmer PE; Kim JY
    World J Surg; 2008 Apr; 32(4):533-6. PubMed ID: 18311574
    [No Abstract]   [Full Text] [Related]  

  • 131. hCG measurement in gestational trophoblastic neoplasia: a critical appraisal.
    Hancock BW
    J Reprod Med; 2006 Nov; 51(11):859-60. PubMed ID: 17165429
    [No Abstract]   [Full Text] [Related]  

  • 132. The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours.
    Powles T; Young A; Sanitt A; Stebbing J; Short D; Bower M; Savage PM; Seckl MJ; Schmid P
    Br J Cancer; 2006 Nov; 95(9):1145-7. PubMed ID: 17031399
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
    Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
    Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system.
    Tocharoenvanich S; Chichareon S; Wootipoom V; Bu-ngachat R; Piyananjarassri K
    J Obstet Gynaecol Res; 2003 Feb; 29(1):20-7. PubMed ID: 12696623
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience.
    Moodley M; Tunkyi K; Moodley J
    Int J Gynecol Cancer; 2003; 13(2):234-9. PubMed ID: 12657130
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 138. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
    Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
    J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Sonographic findings and clinical correlations in molar pregnancy.
    Santos-Ramos R; Forney JP; Schwarz BE
    Obstet Gynecol; 1980 Aug; 56(2):186-92. PubMed ID: 7393507
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate.
    Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
    Am J Obstet Gynecol; 1987 Nov; 157(5):1166-8. PubMed ID: 2825524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.